<DOC>
	<DOCNO>NCT02107664</DOCNO>
	<brief_summary>Radiation therapy ( RT ) one primary treatment bone cancer pain due metastatic cancer disease . About 6 10 patient obtain pain relief RT . There establish predictor use select patient respond RT . This raise need identify potential clinical characteristic biomarkers may better select patient RT . A similar argument state development cachexia ; currently predictor identify patient develop cachexia later cancer disease trajectory . Cancer symptom related inflammation . Both pain , cachexia depression associate inflammation experimental preclinical study . Still , clinical data relationship inflammation pain cachexia sparse . This especially true longitudinal follow-up study . This study include 1000 adult patient multicenter , multinational longitudinal observation study patient receive radiation therapy bone cancer pain . Demographic data , clinical variable , genetic biomarkers inflammatory substance assess start RT . The primary analysis study identify potential predictor pain relief RT . During follow study also explore predictor development cachexia inflammatory substance associate change pain intensity , depression development cachexia .</brief_summary>
	<brief_title>The Palliative Radiotherapy And Inflammation Study - PRAIS</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Bone Neoplasms</mesh_term>
	<criteria>Inclusion criterion : Verified cancer diagnosis ( base radiological , histological , cytological operative evidence ) . Those hematological malignancy also eligible . Bone metastasis verify either bone xray , bone scan , computer tomography ( CT ) magnetic resonance imaging ( MRI ) Patients undergo radiotherapy palliative intent painful bone metastasis Radiotherapy administer within one week baseline observation obtain Age â‰¥18 year Patient able comply trial procedure . Exclusion criterion : Pathological fracture long bone ( e.g femora humeral shaft fracture ) Patients consent participate study Ongoing RT RT administer within last 4 week Patients able follow trial procedure Previous participation study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Radiotherapy</keyword>
	<keyword>Cachexia</keyword>
	<keyword>Inflammation</keyword>
	<keyword>Depression</keyword>
</DOC>